Key result
Metabolic syndrome is linked to cardiovascular autonomic dysfunction in ~87% of young type 2 diabetics.
Why the study?
Is metabolic syndrome associated with a higher prevalence and severity of impaired cardiovascular autonomic function in patients aged 55 years or younger with type 2 diabetes?
Cross-Sectional (n=180)
No
Is metabolic syndrome associated with a higher prevalence and severity of impaired cardiovascular autonomic function in patients aged 55 years or younger with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
In patients aged 55 years or younger with type 2 diabetes, concomitant metabolic syndrome, overweight, and HbA1c > 7% are strongly associated with early cardiovascular autonomic dysfunction, highlighting the need for early autonomic screening and aggressive metabolic control.
BACKGROUND: Type 2 diabetes (T2D) might occur within metabolic syndrome (MbS). One of the complications of T2D is an impaired (imp) cardiovascular autonomic function (CAF). AIMS: In subjects with T2D and age ≤ 55 years, the prevalence of impCAF and its relationship with BMI, waist, HbA(1c) values, MbS, hypertension, and family history of T2D and/or hypertension were analysed. METHODS: 180 subjects consecutively undergoing a day hospital for T2D were studied. The IDF criteria were used to diagnose MbS. To detect impCAF, 5 tests for the evaluation of CAF were performed with Cardionomic (Meteda, Italy). Univariate and multivariate analyses were performed. RESULTS: The prevalence of impCAF and MbS were 33.9% and 67.8%, respectively. Among diabetics with impCAF, 86.9% had MbS. ImpCAF was significantly associated with MbS, overweight, and HbA(1c) > 7%. Both logistic (P = 0.0009) and Poisson (P = 0.0113) models showed a positive association between impCAF and MbS. The degree of ImpCAF showed a positive linear correlation with BMI and HbA(1c) values. CONCLUSIONS: The study demonstrates that glycaemic control and overweight influence CAF and that T2D + MbS is more strongly associated with impCAF than isolated T2D. We suggest that MbS not only increases the cardiovascular risk of relatively young subjects with T2D but is also associated with impCAF.
No takes yet. Share an insight, caveat, or question.
Garruti et al. (2012) conducted a cross-sectional in Type 2 diabetes mellitus (n=180). Metabolic syndrome (IDF criteria) vs. Isolated type 2 diabetes without metabolic syndrome was evaluated on Impaired cardiovascular autonomic function (at least 1 of 5 abnormal cardiovascular reflex tests) (p=0.0009). Metabolic syndrome was present in 86.9% of young type 2 diabetics with impaired cardiovascular autonomic function and was associated with autonomic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: